title: Relaxin as novel strategy in the management of atrial fibrillation: potential roles and future perspectives.
authors.affiliation: Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
authors.forename: Zhiqiang
authors.initials: Z
authors.lastname: Zhao
authors.affiliation: Department of Cardiology, Loma Linda University Medical Center, CA, United States.
authors.forename: Chee Yuan
authors.initials: CY
authors.lastname: Ng
authors.affiliation: Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
authors.forename: Tong
authors.initials: T
authors.lastname: Liu
authors.affiliation: Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
authors.forename: Hongmin
authors.initials: H
authors.lastname: Li
authors.affiliation: Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China. Electronic address: gp_limail@sina.com.
authors.forename: Guangping
authors.initials: G
authors.lastname: Li
mesh_terms: D000818:Animals; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000188:drug therapy*; D019468:Disease Management; D005544:Forecasting; D006801:Humans; D012065:Relaxin / Q000627:therapeutic use*
chemical_list: D012065:Relaxin
keywords: Atrial fibrillation; Fibrosis; Inflammation; Oxidative stress; Relaxin